Cargando…
Editorial: Sickle cell disease in the 21st century—Morbidity to molecular biology
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9792965/ https://www.ncbi.nlm.nih.gov/pubmed/36582286 http://dx.doi.org/10.3389/fmed.2022.1100846 |
| _version_ | 1784859750397116416 |
|---|---|
| author | Mohanty, Dipika |
| author_facet | Mohanty, Dipika |
| author_sort | Mohanty, Dipika |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9792965 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Frontiers Media S.A. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-97929652022-12-28 Editorial: Sickle cell disease in the 21st century—Morbidity to molecular biology Mohanty, Dipika Front Med (Lausanne) Medicine Frontiers Media S.A. 2022-12-13 /pmc/articles/PMC9792965/ /pubmed/36582286 http://dx.doi.org/10.3389/fmed.2022.1100846 Text en Copyright © 2022 Mohanty. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
| spellingShingle | Medicine Mohanty, Dipika Editorial: Sickle cell disease in the 21st century—Morbidity to molecular biology |
| title | Editorial: Sickle cell disease in the 21st century—Morbidity to molecular biology |
| title_full | Editorial: Sickle cell disease in the 21st century—Morbidity to molecular biology |
| title_fullStr | Editorial: Sickle cell disease in the 21st century—Morbidity to molecular biology |
| title_full_unstemmed | Editorial: Sickle cell disease in the 21st century—Morbidity to molecular biology |
| title_short | Editorial: Sickle cell disease in the 21st century—Morbidity to molecular biology |
| title_sort | editorial: sickle cell disease in the 21st century—morbidity to molecular biology |
| topic | Medicine |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9792965/ https://www.ncbi.nlm.nih.gov/pubmed/36582286 http://dx.doi.org/10.3389/fmed.2022.1100846 |
| work_keys_str_mv | AT mohantydipika editorialsicklecelldiseaseinthe21stcenturymorbiditytomolecularbiology |